ExodusPoint Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
GCM
ExodusPoint Capital Management's CELL Position: Q2 2022 in Review
ExodusPoint Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 18,676 shares — an estimated $133K sold.
ExodusPoint Capital Management first reported a position in CELL in Q3 2021 and held it in 3 quarters. The position peaked at $965K in Q3 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.
- ExodusPoint Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- ExodusPoint Capital Management sold 18,676 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $133K.
- ExodusPoint Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 3 quarters.
- ExodusPoint Capital Management's PhenomeX Inc. Common Stock position peaked at $965K in Q3 2021.
- 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.
Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.